FM
funds managed by abrdn Inc.
Philadelphia, Pennsylvania, United StatesFounded 2005
funds managed by abrdn Inc. is a Series A to Series C stage investment firm based in Philadelphia, Pennsylvania, United States. It has made 3 investments, with focus areas including Biotech & Life Sciences. 100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-c (67% of deals). Average disclosed round size is $108.5M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
—
Top Stage
Series C
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Third Arc Bio Inc. | Series A | $52M | Feb 2026 |
 Arbor Biotechnologies Inc | Series C | $73.9M | Mar 2025 |
 Aviceda Therapeutics | Series C | $199.6M | — |
Top Co-Investors
Omega Funds2 shared
Marshall Wace2 shared
Andreessen Horowitz1 shared
Hillhouse Capital1 shared
Life Sciences at Goldman Sachs Alternatives1 shared
BVF Partners LP1 shared
Enavate Sciences1 shared
Longitude Capital1 shared
OrbiMed1 shared
Logos Capital1 shared
Catalio Capital Management1 shared
Digitalis Ventures1 shared
Jeito Capital1 shared
Temasek Holdings1 shared
T. Rowe Price1 shared
ARCH Venture Partners1 shared
Qatar Investment Authority1 shared
Revelation Partners1 shared
Ally Bridge Group1 shared
Last updated: 16 April 2026